These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 15735614)

  • 1. BIBN4096BS antagonizes human alpha-calcitonin gene related peptide-induced headache and extracerebral artery dilatation.
    Petersen KA; Lassen LH; Birk S; Lesko L; Olesen J
    Clin Pharmacol Ther; 2005 Mar; 77(3):202-13. PubMed ID: 15735614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of the non-peptide CGRP receptor antagonist BIBN4096BS in blocking CGRP-induced dilations in human and bovine cerebral arteries: potential implications in acute migraine treatment.
    Moreno MJ; Abounader R; Hébert E; Doods H; Hamel E
    Neuropharmacology; 2002 Mar; 42(4):568-76. PubMed ID: 11955527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effect of BIBN4096BS on cephalic vasodilatation induced by CGRP or transcranial electrical stimulation in the rat.
    Petersen KA; Birk S; Doods H; Edvinsson L; Olesen J
    Br J Pharmacol; 2004 Nov; 143(6):697-704. PubMed ID: 15504760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CGRP-antagonist, BIBN4096BS does not affect cerebral or systemic haemodynamics in healthy volunteers.
    Petersen KA; Birk S; Lassen LH; Kruuse C; Jonassen O; Lesko L; Olesen J
    Cephalalgia; 2005 Feb; 25(2):139-47. PubMed ID: 15658951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the calcitonin gene-related peptide (CGRP) receptor antagonist BIBN4096BS on alpha-CGRP-induced regional haemodynamic changes in anaesthetised rats.
    Arulmani U; Schuijt MP; Heiligers JP; Willems EW; Villalón CM; Saxena PR
    Basic Clin Pharmacol Toxicol; 2004 Jun; 94(6):291-7. PubMed ID: 15228501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effect of BIBN4096BS, CGRP(8-37), a CGRP antibody and an RNA-Spiegelmer on CGRP induced vasodilatation in the perfused and non-perfused rat middle cerebral artery.
    Edvinsson L; Nilsson E; Jansen-Olesen I
    Br J Pharmacol; 2007 Mar; 150(5):633-40. PubMed ID: 17245362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterisation of CGRP receptors in the human isolated middle meningeal artery.
    Gupta S; Mehrotra S; Avezaat CJ; Villalón CM; Saxena PR; Maassenvandenbrink A
    Life Sci; 2006 Jun; 79(3):265-71. PubMed ID: 16458930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterisation of CGRP receptors in human and porcine isolated coronary arteries: evidence for CGRP receptor heterogeneity.
    Gupta S; Mehrotra S; Villalón CM; Garrelds IM; de Vries R; van Kats JP; Sharma HS; Saxena PR; Maassenvandenbrink A
    Eur J Pharmacol; 2006 Jan; 530(1-2):107-16. PubMed ID: 16375887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Influence of Calcitonin Gene-Related Peptide on Cerebral Hemodynamics in Nonmigraine Subjects with Calcitonin Gene-Related Peptide-Induced Headaches.
    Zupan M; Zaletel M; Visočnik D; Žvan B
    Biomed Res Int; 2021; 2021():5540254. PubMed ID: 33981769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the CGRP receptor antagonist BIBN4096BS in human cerebral, coronary and omental arteries and in SK-N-MC cells.
    Edvinsson L; Alm R; Shaw D; Rutledge RZ; Koblan KS; Longmore J; Kane SA
    Eur J Pharmacol; 2002 Jan; 434(1-2):49-53. PubMed ID: 11755165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The phosphodiesterase 5 inhibitor sildenafil has no effect on cerebral blood flow or blood velocity, but nevertheless induces headache in healthy subjects.
    Kruuse C; Thomsen LL; Jacobsen TB; Olesen J
    J Cereb Blood Flow Metab; 2002 Sep; 22(9):1124-31. PubMed ID: 12218418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of calcitonin gene-related peptide in migraine: regional cerebral blood flow and blood flow velocity in migraine patients.
    Lassen LH; Jacobsen VB; Haderslev PA; Sperling B; Iversen HK; Olesen J; Tfelt-Hansen P
    J Headache Pain; 2008 Jun; 9(3):151-7. PubMed ID: 18437288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of BIBN4096BS on cardiac output distribution and on CGRP-induced carotid haemodynamic responses in the pig.
    Kapoor K; Arulmani U; Heiligers JP; Willems EW; Doods H; Villalón CM; Saxena PR
    Eur J Pharmacol; 2003 Aug; 475(1-3):69-77. PubMed ID: 12954361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Migraine can be induced by sildenafil without changes in middle cerebral artery diameter.
    Kruuse C; Thomsen LL; Birk S; Olesen J
    Brain; 2003 Jan; 126(Pt 1):241-7. PubMed ID: 12477710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of K ATP channels in cephalic vasodilatation induced by calcitonin gene-related peptide, nitric oxide, and transcranial electrical stimulation in the rat.
    Gozalov A; Jansen-Olesen I; Klaerke D; Olesen J
    Headache; 2008 Sep; 48(8):1202-13. PubMed ID: 18647185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BIBN4096BS and CGRP(8-37) antagonize the relaxant effects of alpha-CGRP more than those of beta-CGRP in human extracranial arteries.
    Verheggen R; Wojtas K; Webel M; Hoffmann S; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 2005 May; 371(5):383-92. PubMed ID: 15983761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BIBN4096BS is a potent competitive antagonist of the relaxant effects of alpha-CGRP on human temporal artery: comparison with CGRP(8-37).
    Verheggen R; Bumann K; Kaumann AJ
    Br J Pharmacol; 2002 May; 136(1):120-6. PubMed ID: 11976276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding properties of the novel, non-peptide CGRP receptor antagonist radioligand, [(3)H]BIBN4096BS.
    Schindler M; Doods HN
    Eur J Pharmacol; 2002 May; 442(3):187-93. PubMed ID: 12065071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcitonin gene-related peptide (CGRP) modulates nociceptive trigeminovascular transmission in the cat.
    Storer RJ; Akerman S; Goadsby PJ
    Br J Pharmacol; 2004 Aug; 142(7):1171-81. PubMed ID: 15237097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and potential of non-peptide antagonists for calcitonin-gene-related peptide (CGRP) receptors: evidence for CGRP receptor heterogeneity.
    Wu D; Doods H; Arndt K; Schindler M
    Biochem Soc Trans; 2002 Aug; 30(4):468-73. PubMed ID: 12196117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.